| Customization: | Available |
|---|---|
| CAS No.: | 872365-14-5 |
| Formula: | C19h17f3n2o4s |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
1.Free Samples.
|
Chemical name
|
Fevipiprant |
|
CAS No.
|
872365-14-5 |
|
MF:
|
C24H19FN2O3
|
|
MW:
|
402.4176632
|
|
Purity
|
98%min
|
|
Certificate
|
ISO 9001
|
|
Storage Temperature
|
Cool Dry Place
|
Fevipiprant, a drug primarily used to treat asthma, has recently been explored for its potential use in hair care. There is evidence to suggest a link between hair loss and inflammation in the scalp, and fevipiprant's anti-inflammatory properties could provide benefits for those experiencing hair loss or thinning.
Studies have shown that fevipiprant can reduce levels of certain inflammatory molecules in the scalp which contribute to hair loss. This suggests that fevipiprant could potentially be used as a preventative treatment for hair loss, particularly in individuals with underlying inflammatory scalp conditions.
Furthermore, fevipiprant may also promote hair growth. A study conducted on mice showed that treatment with fevipiprant increased hair growth and thickness compared to a control group. While more research is needed to determine its effectiveness in humans, these preliminary findings suggest that fevipiprant could have a positive impact on hair growth.
Function of Fevipiprant CAS 872365-14-5
Fevipiprant, also known as NVP-QAW039 or QAW039, is an oral active and potent CRTh2 receptor antagonist and potentially useful for asthma treatment. [(3)H]-QAW039 displayed high affinity for the human CRTh2 receptor (1.14 ± 0.44 nM) expressed in Chinese hamster ovary cells, the binding being reversible and competitive with the native agonist prostaglandin D2(PGD2). QAW039 was also a potent inhibitor of PGD2-induced cytokine release in human Th2 cells. Fevipiprant reduces eosinophilic airway inflammation and is well tolerated in patients with persistent moderate-to-severe asthma and raised sputum eosinophil counts despite inhaled corticosteroid treatment. Fevipiprant demonstrates a favorable safety profile.
Fevipiprant is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.
Q&A
1.How could l get a sample?
Before we received the first order, please afford the sample cost and express fee. We wilreturn the sample cost back to you within your first order.
2.Can you make designs for us?
We have a professional design team to help our customers do design work.Both OEM and ODM orders are accepted.
3.Can we get samples from your factory?
We can provide you samples for free, you just pay express cost.
4.Whether you could make our brand on your products?
Yes. We can print your Logo on both the products and the packages if you can meet our MOQ
How can you provide us high quality products?
5.We have a professional QC team, every product is shipped after strictly examination.
What is your lead time?
Quantity about 10000 pcs is 15-20 days ,small orders are about one week.
Huge orders to be neqotiated.
6.What is your payment?
We accept T/T.L/C.Westem union or to be negotiated.Don't worry about anything, if you have any problems, please feel free to contact us
){kind=link}